Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Cancer Letters|February 7, 2012
Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapyBrian J Park, Zakary L Whichard, Seth J Corey
Pediatric Blood & Cancer|November 7, 2025
Oral and Dental Management in Children With Congenital NeutropeniaDany A Curi, Nathalie C Kabbani, Seth J Corey
Computational and Systems Oncology|September 20, 2021
Predicting Time to Relapse in Acute Myeloid Leukemia through Stochastic Modeling of Minimal Residual Disease Based on Clonality DataKhanh N Dinh, Roman Jaksik, Seth J Corey, et al.
Pediatric Blood & Cancer|May 6, 2017
Synonymous mutation in TP53 results in a cryptic splice site affecting its DNA-binding site in an adolescent with two primary sarcomasFrances Austin, Usua Oyarbide, Gita Massey, et al.
Leukemia Research|January 17, 2002
Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridolIgor Semenov, Canan Akyuz, Vera Roginskaya, et al.
The Journal of Biological Chemistry|June 4, 2004
A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2Yun Dai, Mohamed Rahmani, Seth J Corey, et al.
Blood|January 28, 2010
Hematopoiesis and its disorders: a systems biology approachZakary L Whichard, Casim A Sarkar, Marek Kimmel, et al.
Hematology/Oncology Clinics of North America|January 29, 2013
ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiologyMarshall S Horwitz, Seth J Corey, H Leighton Grimes, et al.
Haematologica|May 25, 2023
Shwachman-Diamond syndromes: clinical, genetic, and biochemical insights from the rare variantsNozomu Kawashima, Usua Oyarbide, Marco Cipolli, et al.
The Journal of Biological Chemistry|November 6, 2010
Slowly produced microRNAs control protein levelsZakary L Whichard, Adilson E Motter, Peter J Stein, et al.
Pageof 11